2006-July Archives by Date
Starting: Sat Jul 1 04:36:08 2006
Ending: Mon Jul 31 14:37:04 2006
Messages: 116
- [Ip-health] TWN Info Service: Development meeting begins; FOD Group submits new paper
Sangeeta
- [Ip-health] TWN Info Service:Differences re-emerge on development proposals
Sangeeta
- [Ip-health] TWN Info Service: Continuing differences at WIPO development meeting
Sangeeta
- [Ip-health] IP-Watch: WIPO Development Agenda Talks End With No Agreement For
Now
Thiru Balasubramaniam
- [Ip-health] FromGeneva (morning session-1st day of WIPO PCDA): WIPO Development
Agenda meeting currently in informal discussions on procedure
Thiru Balasubramaniam
- [Ip-health] AIDS Treatment News on approval and pricing of new protease inhibitor
Mike Palmedo
- [Ip-health] Celgene to Price Cancer Medicine At $6,195 a Month
James Love
- [Ip-health] $6,195 a Month for Celgene's Cancer Drug: Is There a Better Way to Reward Successful Drug Development?
James Love
- [Ip-health] Aidan Hollis comment on prize fund approach
James Love
- [Ip-health] Sangeeta on WIPO: Uncertainty as Development Agenda talks end without result
James Love
- [Ip-health] EU Commission initial findings on Patent policy
Michelle Childs
- [Ip-health] Le Matin (Swiss paper): Soupcons de malversations dans une organisation
internationale
Thiru Balasubramaniam
- [Ip-health] Finnish EU Presidency- New Innovation Policy a priority
Michelle Childs
- [Ip-health] AIDS Update: DATA Report: G8 Countries Have Fallen Short on HIV/AIDS, Development Promises Made at 2005 Summit; Kaletra tablet (no need for refrig) approved
Ann-Marie Sevcsik
- [Ip-health] Boy plunges to death after taking controversial 'tamiflu' drug
Chieko Kurihara
- [Ip-health] MSF: ABBOTT PICKS AND CHOOSES WHICH PATIENTS GET CRUCIAL NEW VERSION OF
AIDS DRUG
Kate Evans
- [Ip-health] NYT: New AIDS Pill to Treat People in Poor Countries
Amy Nunn
- [Ip-health] Bridges Weekly: WIPO Development Agenda Meeting Breaks down over
Chair's text
Thiru Balasubramaniam
- [Ip-health] $6,195 a Month for Celgene's Cancer Drug: Is
Ther e a Better Way to Reward Successful Drug Development?
Corey, Beverly F
- [Ip-health] Biolyse succeeds in getting Canadian government to list generic Tamiflu (oseltamivir) for waiver of WTO/Nafta rules on exports of medicines
James Love
- [Ip-health] Wall Street Journal: Global Vaccine Initiative Hits Snag
Thiru Balasubramaniam
- [Ip-health] Robert Goldberg on the Prize of Revlimid
James Love
- [Ip-health] WSJ:Global Vaccine Initiative Hits Snag
Amy Nunn
- [Ip-health] Modeling prize fund rewards
James Love
- [Ip-health] Update on Access Bill at July 13 Brownbag 12-2pm at CPTech
Manon Ress
- [Ip-health] Advance Market Commitments in G8 pre-summit statement
James Love
- [Ip-health] Harvey Bale and Christopher Earl's July 3 FT op-ed on G8 Advance Market Commitment discussions
James Love
- [Ip-health] US-Korea Free Trade Protests in Seoul
robert weissman
- [Ip-health] CPTech comments on the APC/AMC approaches
James Love
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Mike Palmedo
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Joseph DiMasi
- [Ip-health] European Parliament resolution on HIV/AIDS: Time to Deliver
Alexandra HEUMBER
- [Ip-health] Hankyoreh: Seoul, Washington differ in approach to preliminary free
trade talks
Mike Palmedo
- [Ip-health] The Hankyoreh: Bipartisan criticism raised against free trade approach
- Government ignoring citizens, groups say
Mike Palmedo
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
James Love
- [Ip-health] Conceding data exclusivity will damage domestic drug industry - Dr.
Joshi
Mike Palmedo
- [Ip-health] Puerto Rico Rx Price Controls
Flynn, Sean M.
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Mike Palmedo
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Joseph DiMasi
- [Ip-health] FromGeneva: Public Domain & Open Standards discussion at WIPO: What
did Mexico, India, Chile and Australia say?
Thiru Balasubramaniam
- [Ip-health] Bloomberg: S Korea Deploys 100,000 Police Against FTA Protesters
Mike Palmedo
- [Ip-health] Korea Herald: Pharmaceuticals Contentious Issue in FTA
Mike Palmedo
- [Ip-health] suspended talks on pharmaceuticals in KORUS FTA
heeseob nam
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
James Love
- [Ip-health] Reminder Brownbag re FRPAA July 13, 2006 12-2pm
Manon Ress
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Joseph DiMasi
- [Ip-health] Korea FTA negotiations on medicines will harm us too
James Love
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
James Love
- [Ip-health] IP-Watch: Idris's Age Corrected AT WIPO Admidst Speculation Of Benefit-Seeking
Thiru Balasubramaniam
- [Ip-health] CPtech's intervention at EU Patent Hearing 12th July
Michelle Childs
- [Ip-health] Thailand: Bitter Medicine
Stephanie Weinberg
- [Ip-health] Written declaration on international penalties for counterfeiting
medicines
Alexandra HEUMBER
- [Ip-health] Viropro and technology transfer for biogenerics
=?iso-8859-1?Q?Marc-Andr=E9_Gagnon?=
- [Ip-health] House International Relations Comm Hearing on Asian FTAs
Mike Palmedo
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
Joseph DiMasi
- [Ip-health] Initiative for Medicines, Acces & Knowledge Report on TRIPS 39.3
In India
Mike Palmedo
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004
Approvals
Jon Merz
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004
Approvals
Joel Lexchin
- [Ip-health] Re: suspended talks on pharmaceuticals in KORUS FTA
heeseob nam
- [Ip-health] Korea FTA negotiations on medicines will harm us too
heeseob nam
- [Ip-health] John Kilama featured in "People" section of IP-Watch
Thiru Balasubramaniam
- [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals
James Love
- [Ip-health] USTR press release on KORUS FTA
Stephanie Weinberg
- [Ip-health] DNA India: Data exclusivity, a Trojan horse?
Mike Palmedo
- [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared
James Love
- [Ip-health] Korea opposition to US/FTA proposals
James Love
- [Ip-health] India/France IPR bilateral agreement
James Love
- [Ip-health] USCIB Committee on Intellectual Property - Recent Accomplishments
James Love
- [Ip-health] G8 statement -- Fight against infectious diseases
James Love
- [Ip-health] IHT, NYT: G-8's drug aid for poor catches an ailment: politics
Sheila.SHETTLE@geneva.msf.org
- [Ip-health] Dong-A Ilbo: FTA Talks Stall on Lack of Compromise
Mike Palmedo
- [Ip-health] Re: India/France IPR bilateral agreement
gerrold@noos.fr
- [Ip-health] Health Versus Wealth: The Thai Frontier
Mike Palmedo
- [Ip-health] balance of patent royalties and licenses
heeseob nam
- [Ip-health] UK model research agreements between business and universities.
Michelle Childs
- [Ip-health] Re: Clients Course Needs Assesment Questionnaire
Taabco
- [Ip-health] Oxfam Urgent Action: Congress Set to Vote on US-Peru Free Trade Agreement
Mike Palmedo
- [Ip-health] Kenya Broadcasting Corp - Coalition Against Change of Patent Act
Mike Palmedo
- [Ip-health] [KoreaHerald] Seoul reaffirms FTA stance
heeseob nam
- [Ip-health] Times of India: Firms ready with cheaper AIDS drugs
Sheila.SHETTLE@geneva.msf.org
- [Ip-health] Statement on 2nd round of KORUS FTA
heeseob nam
- [Ip-health] Wall Street Journal: Gates Won't Fund AIDS Researchers Unless They Pool Data
Thiru Balasubramaniam
- [Ip-health] Forbes: String Attached: Gates AIDS Gift Requires Collaboration
Mike Palmedo
- [Ip-health] FTC Testifies on Barriers to the Entry of Generic Drugs
Mike Palmedo
- [Ip-health] U.S. government pushed Korea to drop new drug policy
heeseob nam
- [Ip-health] The Lancet: Is access to essential medicines as part of the fulfilment
of the right to health enforceable through the courts?
Ira Glazer
- [Ip-health] Kenyan activists:
"Patents over patients, we need your support in protesting"
Asia Russell
- [Ip-health] Aidan Hollis: Off-label prescribing and rewards based on observed value
James Love
- [Ip-health] Copying the generics: FDA OKs new 1-a-day dose of 3-drug combination
to fight AIDS
Ira Glazer
- [Ip-health] IP-Watch: WHO IP Working Group To Address Conflicting Interests Before
December Meeting
Thiru Balasubramaniam
- [Ip-health] EU Com McCreevy's future of patent policy speech
Michelle Childs
- [Ip-health] A Korea-U.S. trade agreement: what is at stake? - Dean Baker
Dan Beeton
- [Ip-health] MOHW Proposes Reformation Bill for Drug Costs
heeseob nam
- [Ip-health] Kenyan civil society statement: OUR LIVES OVER PATENT RIGHTS!!
Mike Palmedo
- [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of
Drugs by 300 Percent
Mike Palmedo
- [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of Drugs by 300 Percent
=?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
- [Ip-health] GSK announces avian flu vaccine breakthrough
Ira Glazer
- [Ip-health] Biosimilar drugs
Dolores Cullen
- [Ip-health] Copying the generics: FDA OKs new 1-a-day dose of
3-drug combination to fight AIDS
Hember, Miles
- [Ip-health] Size of trials by status (S or P) - Some 2004 FDA
and Parexcel data compared
Joseph DiMasi
- [Ip-health] Bridges Weekly: US-KOREA FTA TALKS END EARLY AMIDST DISAGREEMENT
Thiru Balasubramaniam
- [Ip-health] PhRMA statement on Korean drug pricing policy
heeseob nam
- [Ip-health] Salon: "Biosimilar," but not identical
Thiru Balasubramaniam
- [Ip-health] Patent Oppositions Filed on 3 Essential Drugs
chan park
- [Ip-health] Forum for Health Economics and Policy - recently posted articles
James Love
- [Ip-health] Salon: "Biosimilar," but not identical
Hember, Miles
- [Ip-health] Salon: "Biosimilar," but not identical
Dolores Cullen
- [Ip-health] Cancer care can sap a lifetime of savings
Joana Ramos
- [Ip-health] Wall Street Journal: FBI Raids Offices At Bristol-Myers Over Plavix
Deal
Thiru Balasubramaniam
- [Ip-health] Drug Makers Pay for Lunch as They Pitch
James Love
- [Ip-health] Government website on Canadian law on compulsory licensing of pharmaceuticals for export
Richard Elliott
- [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared
James Love
- [Ip-health] Wall Street Journal: At a Crossroads: Failed Trade Talks Cloud WTO's
Future
Thiru Balasubramaniam
- [Ip-health] =?iso-8859-1?Q?NOUVELLE_PUBLICATION:_Gu=EDa_Pr=E1ctica_sobre_la_OMC_-_NEW?=
=?iso-8859-1?Q?_PUBLICATION:_Gu=EDa_Pr=E1ctica_sobre_la_OMC__________18?=
3D -> Trade - Human Rights - Equitable Economy
- Fwd: [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of Drugs by 300 Percent
Gaelle Krikorian
- [Ip-health] Kenya: Reprieve As Karua Acts to Keep Aids Drugs Cheap
Mike Palmedo
Last message date:
Mon Jul 31 14:37:04 2006
Archived on: Mon Jul 31 13:37:05 2006
This archive was generated by
Pipermail 0.05 (Mailman edition).